Cargando…
Plasma growth differentiation factor 15 predicts first-ever stroke in hypertensive patients
Growth differentiation factor 15 (GDF-15) is a relatively new biomarker that predicts adverse stroke outcomes. However, the association of GDF-15 with first-ever stroke in hypertensive patients has not yet been evaluated. The objective of this study was to evaluate the clinical implications of plasm...
Autores principales: | Wang, Xiaojian, Zhu, Ling, Wu, Yan, Sun, Kai, Su, Ming, Yu, Liping, Chen, Jingzhou, Li, Weiju, Yang, Jing, Yuan, Zuyi, Hui, Rutai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265855/ https://www.ncbi.nlm.nih.gov/pubmed/27472718 http://dx.doi.org/10.1097/MD.0000000000004342 |
Ejemplares similares
-
Differential Expression of Hypertension-Associated MicroRNAs in the Plasma of Patients With White Coat Hypertension
por: Cengiz, Mahir, et al.
Publicado: (2015) -
Value of plasma homocysteine to predict stroke, cardiovascular diseases, and new-onset hypertension: A retrospective cohort study
por: Feng, Yuanyuan, et al.
Publicado: (2020) -
Real role of β-blockers in regression of left ventricular mass in hypertension patients: Bayesian network meta-analysis
por: Xing, FuWei, et al.
Publicado: (2017) -
Effectiveness and safety of valsartan/amlodipine in hypertensive patients with stroke: China Status II subanalysis
por: Zhang, Weiliang, et al.
Publicado: (2017) -
Elevated plasma migration inhibitory factor in hypertension–hyperlipidemia patients correlates with impaired endothelial function
por: Zhou, Boda, et al.
Publicado: (2016)